Mechanism of Achyranthes bidentata Bl.-Taxillus chinensis Danser in the treatment of osteoarthritis based on network pharmacology

doi:10.3969/j.issn.2095-4344.2785

Abstract

Abstract:

BACKGROUND: Achyranthes bidentata Bl.-Taxillus chinensis Danser is the most commonly used drug combination for clinical treatment of osteoarthritis, but its pharmacological mechanism is not clear.

OBJECTIVE: To screen the main active chemical constituents of Achyranthes bidentata Bl.-Taxillus chinensis Danser based on the method of network pharmacology, collect the targets corresponding to the compounds, and build a drug-active ingredient-potential target network for treating osteoarthritis to treat bones and joints, and to systematically elucidate the pharmacological mechanism of inflammation.

METHODS: The TCMSP database was used to obtain the active ingredients and targets of Achyranthes bidentata Bl.-Taxillus chinensis Danser, and the targets of osteoarthritis diseases obtained from the DisGeNET and GENE databases were intersected to screen out potential targets for the treatment of osteoarthritis by Achyranthes bidentata Bl.-Taxillus chinensis Danser. Using the String database and Cytoscape 3.6.1 software, we built a drug-active ingredient-therapeutic osteoarthritis potential target network and a protein-protein interaction network between potential targets. At the same time, the gene ontology (GO) biological function and Kyoto Encyclopedia of Genes and Gnomes (KEGG) pathway enrichment of potential targets were analyzed through the Omicshare cloud platform and DAVID database.

RESULTS AND CONCLUSION: A total of 21 active ingredients and 48 potential targets for the prevention and treatment of osteoarthritis were screened from Achyranthes bidentata Bl.-Taxillus chinensis Danser. A total of 1 970 GO entries were obtained by GO enrichment analysis, of which 1 862 were biological processes, 29 were cellular components, and 79 were molecular functions (P < 0.01). KEGG pathway enrichment analysis screened out 76 potential signaling pathways for Achyranthes bidentata Bl.-Taxillus chinensis Danser to prevent osteoarthritis (P < 0.01). These findings indicate that Achyranthes bidentata Bl.-Taxillus chinensis Danser affects multiple metabolic pathways, affects different metabolic pathways that interacts and coordinates with each other, thereby preventing and curing osteoarthritis. This study tentatively explains the mechanism of the prevention and treatment of osteoarthritis by multi-component-multi-target-multi-pathway in Achyranthes bidentata Bl.-Taxillus chinensis Danser, which provides new ideas and clues for the prevention and treatment of osteoarthritis.

Key words: network pharmacology, osteoarthritis, Achyranthes bidentata Bl., Taxillus chinensis Danser, target, signal pathway

CLC Number:

Huang Zeling, He Junjun, Shi Shanni, Gao Hongjian, Hong Zhenqiang. Mechanism of Achyranthes bidentata Bl.-Taxillus chinensis Danser in the treatment of osteoarthritis based on network pharmacology[J]. Chinese Journal of Tissue Engineering Research, 2020, 24(29): 4599-4604.

Figures/Tables 7

References

[1] SACITHARAN PK. Ageing and osteoarthritis.Subcell Biochem. 2019;91:123-159..

[2] 刘昌孝.对中药现代化及中药国际化发展的思考[J].中国药房, 2016,27(11):1441-1444.

[3] 郭梦如,何东仪.骨关节炎治疗的中医药研究进展[J].风湿病与关节炎,2019,8(1):73-75.

[4] 秦娜,魏立伟,刘晓红,等.基于数据挖掘的平乐郭氏传统药物治疗骨性关节炎的用药规律研究[J].时珍国医国药, 2017,28(1): 242-243.

[5] 吕东富.痹证用药规律研究[D].南京:南京中医药大学,2006.

[6] 高曼.基于中医传承辅助系统分析中药治疗膝骨关节炎的应用规律[D].北京:北京中医药大学,2019.

[7] HOPKINS AL.Network pharmacology.Nat Biotechnol. 2007; 25(10):1110-1111.

[8] HUANG C, ZHENG C, LI Y, et al. Systems pharmacology in drug discovery and therapeutic insight for herbal medicines. Brief Bioinform. 2014;15(5):710-733.

[9] 王卓,石忠峰,王凤云,等.基于网络药理学研究寒湿痹颗粒治疗强直性脊柱炎的机制[J].中国组织工程研究,2020,24(11): 1738-1744.

[10] 葛伟韬,高云,刘珍珠,等.膝骨关节炎中医病名辨识[J].中医杂志, 2016,57(23):1989-1992.

[11] 夏璇,黄清春,何羿婷.独活寄生汤治疗膝骨关节炎临床疗效Meta分析[J].新中医,2018,50(5):208-211.

[12] 陈顺有.壮骨健膝方治疗膝关节骨性关节炎疗效机理的临床研究[D].福州:福建中医学院,2004.

[13] 陈国锋,杜运阿,纪建政,等.补肾祛痛方汽化治疗阳虚寒凝型膝骨关节炎30例[J].中国中西医结合外科杂志,2017,23(4):399-401.

[14] 蔡海东,陈雄.益肾通络方联合针灸推拿治疗膝骨关节炎的临床观察[J].陕西中医,2017,38(3):386-388

[15] 维汉,何耀华.槲皮素在治疗骨关节炎中作用机制的研究进展[J].中华骨与关节外科杂志,2019,12(6):477-480.

[16] KHAN NM, HASEEB A, ANSARI MY,et al. Wogonin, a plant derived small molecule, exerts potent anti-inflammatory and chondroprotective effects through the activation of ROS/ERK/Nrf2 signaling pathways in human Osteoarthritis chondrocytes.Free Radic Biol Med. 2017;106:288-301.

[17] HUANG X, PAN Q, MAO Z, et al. Kaempferol inhibits interleukin 1β stimulated matrix metalloproteinases by suppressing the MAPK associated ERK and P38 signaling pathways. Mol Med Rep. 2018;18(3):2697-2704.

[18] LIAO PC, LAI MH, HSU KP,et al. Identification of β-sitosterol as in vitro anti-inflammatory constituent in moringa oleifera. J Agric Food Chem. 2018;66(41):10748-10759.

[19] 刘威良,姬昱,黄艾祥.β-谷甾醇的研究及开发进展[J].农产品加工, 2019,18(1):77-79+82.

[20] 修佳,张卫华,张振凌.牛膝的药理作用及临床应用研究概况[J].中国药房,2008,19(15):1192-1194.

[21] 朱开昕,苏本伟,李永华,等.桑寄生药理作用及临床应用研究进展[J].现代医学与健康研究电子杂志,2018,2(12):189-190.

[22] DEGEOOT J, VERZIJL N, JACOBS K, et al. Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. Arthritis Rheum. 2004;50:1207-1215.

[23] GARG S, SYNGLE A, VOHAR K. Efficacy and tolerability of advanced glycation end-products inhibitor in osteoarthritis: a randomized, double-blind, placebo-controlled study. Clin J Pain. 2013;29(8):717-724.

[24] 何俊君.阳和汤影响木瓜蛋白酶诱导的兔膝骨关节炎模型滑膜炎症的实验研究[D].福州:福建中医药大学,2019.

[25] HERAUD F, HERAUD A, HARMAND M. Apoptosis in normal and osteoarthritic human articular cartilage. Ann Rheum Dis. 2000;59(12):959-965.

[26] 王文涛,李斯明.骨关节炎关节软骨细胞凋亡的研究进展[J].中国骨科临床与基础研究杂志,2019,11(3):180-188.

[27] 王华敏,宓轶群,刚嘉鸿.信号通路在膝骨关节炎实验研究中的进展[J].中国组织工程研究,2016,20(2):267-272.

[28] 罗淦,汤样华,康仪,等.骨关节炎相关信号通路的研究进展[J].中医正骨,2019,31(5):31-37.